Comprehensive Examination of Coffee Consumption Patterns and Their Impact on Liver Cancer Risk
DOI:
https://doi.org/10.56294/hl2025641Keywords:
Drinking coffee, risk of liver cancer, health prevention, Demographic FactorsAbstract
Coffee consumption has drawn increasing attention for its possible protective belongings against liver cancer, especially among high-risk populations. This research was designed to thoroughly examine the association among coffee intake and liver cancer risk diagonally diverse demographic groups. A cross-sectional survey involving 300 participants was conducted, collecting data on key variables, including age, smoking, alcohol consumption, and levels of coffee intake. Statistical analyses were accomplished utilizing SPSS software, employing logistic regression and chi-square tests to inspect the associations among coffee consumption, demographic factors, and liver cancer risk. The outcomes exposed that higher quantity of coffee intake were crucially linked to a reduced risk of liver cancer compared to lower consumption levels, suggesting a possible dose-response relationship. Among the demographic factors analyzed, age emerged as a substantial risk factor for liver cancer, with older individuals evincing a higher likelihood of expanding the disease. Additionally, smoking and alcohol consumption were recognized as significant lifestyle behaviors providing to liver cancer risk, further emphasizing the complicated nature of the disease. These findings highlight coffee’s possible as a protective dietary intervention for commuting liver cancer risk, especially in populations at greater risk due to age or other lifestyle factors. The study emphasizes the importance of incorporating coffee consumption into broader dietary and public health approaches for cancer prevention. Moreover, it advocates for further research to unravel the mechanisms underlying coffee’s protective effects and to advance adjusted dietary and lifestyle recommendations aimed at appreciably reducing liver cancer risk, eventually promoting improved health outcomes in unprotected populations.
References
1. Reddy VS, Shiva S, Manikantan S, Ramakrishna S. Pharmacology of caffeine and its effects on the human body. European Journal of Medicinal Chemistry Reports. 2024 Feb 27:100138. https://doi.org/10.1016/j.ejmcr.2024.100138
2. Yuan S, Carter P, Mason AM, Burgess S, Larsson SC. Coffee consumption and cardiovascular diseases: a Mendelian randomization study. Nutrients. 2021 Jun 28;13(7):2218. https://doi.org/10.3390/nu13072218
3. Golabi P, Paik JM, Eberly K, de Avila L, Alqahtani SA, Younossi ZM. Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C. Annals of hepatology. 2022 Jan 1;27(1):100556. https://doi.org/10.1016/j.aohep.2021.100556
4. Lowery LM, Anderson DE, Scanlon KF, Stack A, Escalante G, Campbell SC, Kerksick CM, Nelson MT, Ziegenfuss TN, VanDusseldorp TA, Kalman DS. International society of sports nutrition position stand: coffee and sports performance. Journal of the International Society of Sports Nutrition. 2023 Dec 31;20(1):2237952. https://doi.org/10.1080/15502783.2023.2237952
5. Kim SY, Yoo DM, Min C, Choi HG. Association between coffee consumption/physical exercise and gastric, hepatic, colon, breast, uterine cervix, lung, thyroid, prostate, and bladder cancer. Nutrients. 2021 Nov 2;13(11):3927. https://doi.org/10.3390/nu13113927
6. Di Pietrantonio D, Pace Palitti V, Cichelli A, Tacconelli S. Protective Effect of Caffeine and Chlorogenic Acids of Coffee in Liver Disease. Foods. 2024 Jul 20;13(14):2280. https://doi.org/10.3390/foods13142280
7. Ergin E, Tokusoglu O, Vural H. Coffee toxicology, processing of the coffee and liver diseases (is it a miracle of nature?). Journal of Food Processing and Preservation. 2021 Apr;45(4):e15243. https://doi.org/10.1111/jfpp.15243
8. Pauwels EK, Volterrani D. Coffee consumption and cancer risk: An assessment of the health implications based on recent knowledge. Medical Principles and Practice. 2021 Mar 24;30(5):401-11. https://doi.org/10.1159/000516067
9. Niezen S, Mehta M, Jiang ZG, Tapper EB. Coffee consumption is associated with lower liver stiffness: a nationally representative study. Clinical Gastroenterology and Hepatology. 2022 Sep 1;20(9):2032-40. https://doi.org/10.1016/j.cgh.2021.09.042
10. Yen YH, Kee KM, Li WF, Liu YW, Wang CC, Hu TH, Tsai MC, Kuo YH, Lin CY. Causes of death among patients with hepatocellular carcinoma according to chronic liver disease etiology. Cancers. 2023 Mar 9;15(6):1687. https://doi.org/10.3390/cancers15061687
11. Kennedy OJ, Fallowfield JA, Poole R, Hayes PC, Parkes J, Roderick PJ. All coffee types decrease the risk of adverse clinical outcomes in chronic liver disease: A UK Biobank study. BMC Public Health. 2021 Jun 22;21(1): 970.https://doi.org/10.1186/s12889-021-10991-7
12. Carter P, Yuan S, Kar S, Vithayathil M, Mason AM, Burgess S, Larsson SC. Coffee consumption and cancer risk: a Mendelian randomisation study. Clinical Nutrition. 2022 Oct 1;41(10):2113-23. https://doi.org/10.1016/j.clnu.2022.08.019
13. Parra-Lara LG, Mendoza-Urbano DM, Bravo JC, Salamanca CH, Zambrano ÁR. Coffee consumption and its inverse relationship with gastric cancer: An ecological study. Nutrients. 2020 Oct 2;12(10):3028. https://doi.org/10.3390/nu12103028
14. Safe S, Kothari J, Hailemariam A, Upadhyay S, Davidson LA, Chapkin RS. Health benefits of coffee consumption for cancer and other diseases and mechanisms of action. International journal of molecular sciences. 2023 Jan 31;24(3):2706. https://doi.org/10.3390/ijms24032706
15. Zhao L, Zhang X, Yu D, Wang L, Shrubsole MJ, Zheng W, Sudenga SL, Zhang X. Ultra-processed products and risk of liver cancer: A prospective cohort study. Clinical Nutrition. 2024 Oct 1;43(10):2298-304. https://doi.org/10.1016/j.clnu.2024.08.011.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Santosh Mathapati, Pooja Srishtic , Sandeep Kumar Panigrahi , Bhupal Pujari , Kanika Seth, Manvinder Brar, Kollathur Sudheer (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
